{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:10Z","timestamp":1788967210492,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/mpa.0000000000000267","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T16:32:53Z","timestamp":1416501173000},"page":"198-203","source":"Crossref","is-referenced-by-count":35,"title":["Bone Metastases in Well-to-Moderately Differentiated Neuroendocrine Tumors"],"prefix":"10.1097","volume":"44","author":[{"given":"Juraj","family":"Kavecansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Caronia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Teresa","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bloomston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1634\/theoncologist.10-2-123","article-title":"Metastatic carcinoid tumors: a clinical review","volume":"10","author":"Zuetenhorst","year":"2005","journal-title":"Oncologist"},{"key":"R2-4-20210212","first-page":"184","article-title":"Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism","volume":"44","author":"Meijer","year":"2003","journal-title":"J Nucl Med"},{"key":"R3-4-20210212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008215730767","article-title":"Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center","volume":"8","author":"Janson","year":"1997","journal-title":"Ann Oncol"},{"key":"R4-4-20210212","first-page":"CD001793","article-title":"Radiotherapy for the palliation of painful bone metastases","volume":"2","author":"McQuay","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-4-20210212","first-page":"CD689254","article-title":"Evaluation of the clinical benefit of long-term (beyond 2 years) treatment of skeletal-related events in advanced cancers with zoledronic acid","volume":"7","author":"Henk","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"R6-4-20210212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/0973-1075.92338","article-title":"A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis","volume":"17","author":"Choudhury","year":"2011","journal-title":"Indian J Palliat Care"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1634\/theoncologist.2010-0154","article-title":"The role of RANK-ligand inhibition in cancer: the story of denosumab","volume":"16","author":"Castellano","year":"2011","journal-title":"Oncologist"},{"key":"R8-4-20210212","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/bjs.7649","article-title":"Survival and prognostic factors in patients with small bowel carcinoid tumour","volume":"98","author":"Landerholm","year":"2011","journal-title":"Br J Surg"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ecl.2010.12.001","article-title":"The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1258\/acb.2008.008033","article-title":"A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours","volume":"45","author":"Stronge","year":"2008","journal-title":"Ann Clin Biochem"},{"key":"R11-4-20210212","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-0115(00)00167-1","article-title":"Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors","volume":"96","author":"Desai","year":"2001","journal-title":"Regul Pept"},{"key":"R12-4-20210212","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.1158\/1078-0432.CCR-04-0422","article-title":"Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors","volume":"10","author":"Shah","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-007-0521-9","article-title":"Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors","volume":"61","author":"Varker","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/MPA.0b013e3181bc0e77","article-title":"Biochemical testing for neuroendocrine tumors","volume":"38","author":"Vinik","year":"2009","journal-title":"Pancreas"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3949\/ccjm.75a.08002","article-title":"Carcinoid tumors: what should increase our suspicion?","volume":"75","author":"Aggarwal","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"R16-4-20210212","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/1471-2407-10-448","article-title":"Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy","volume":"10","author":"Kim","year":"2010","journal-title":"BMC Cancer"},{"key":"R18-4-20210212","first-page":"224","article-title":"Radiologic diagnosis of bone metastases","volume":"27","author":"Hansmann","year":"1998","journal-title":"Orthopade"},{"key":"R19-4-20210212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/qjmed\/91.4.295","article-title":"Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging","volume":"91","author":"Shi","year":"1998","journal-title":"QJM"},{"key":"R20-4-20210212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.clineuro.2010.01.008","article-title":"Surgical management of carcinoid tumors metastatic to the spine: report of three cases","volume":"112","author":"Arnold","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R21-4-20210212","first-page":"585","article-title":"Metastatic neuroendocrine tumor presenting as spinal cord compression\u2014a case report and brief comment","volume":"65","author":"Bailey","year":"2001","journal-title":"Conn Med"},{"key":"R22-4-20210212","doi-asserted-by":"crossref","first-page":"E510","DOI":"10.1097\/BRS.0b013e3181cb4730","article-title":"Metastatic pancreatic endocrine tumor presenting as thoracic spinal cord compression","volume":"35","author":"Eads","year":"2010","journal-title":"Spine"},{"key":"R23-4-20210212","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11605-007-0089-z","article-title":"Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned","volume":"11","author":"Bloomston","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"R24-4-20210212","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/13543784.2012.679928","article-title":"Progress in the treatment of bone metastases in cancer patients","volume":"21","author":"Mackiewicz-Wysocka","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"R25-4-20210212","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1593\/neo.10282","article-title":"How do bisphosphonates inhibit bone metastasis in vivo?","volume":"12","author":"Fournier","year":"2010","journal-title":"Neoplasia"},{"key":"R26-4-20210212","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/138161210791034003","article-title":"Bisphosphonates as treatment of bone metastases","volume":"16","author":"Holen","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R27-4-20210212","first-page":"411","article-title":"State of the art of palliative therapy","volume":"55","author":"Seregni","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:12:24Z","timestamp":1620965544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201503000-00004"}},"subtitle":["A Single Institutional Review From the Ohio State University Medical Center"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000267","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}